Nutrien is expected to post Q2 2026 consensus revenue of $10.46 billion and EPS of $2.76, with shares currently trading near $69.52 relative to an average analyst price target of $81.84.
Investors are primarily focused on the stability of potash and nitrogen sales volumes and realized pricing amid a cautious outlook for global fertilizer demand. While the company achieved record potash volumes earlier in the year, recent analyst downgrades highlight concerns over margin compression from volatile input costs such as ammonia and sulfur.
Management's ability to sustain the recovery in its Retail segment and confirm upbeat full-year 2026 guidance will be critical for sentiment following a period of sector-wide price volatility.